Pro Dex (PDEX) Non Operating Investment Income (2013 - 2026)
Pro Dex (PDEX) posted Non Operating Investment Income of $2.4 million for Q1 2026, up 1057.6% sequentially from -$250000.0 in Q4 2025, and up 109.08% YoY from $1.1 million in Q1 2025.
Pro Dex (PDEX) Non Operating Investment Income (2013 - 2026) Analysis & Trends
Pro Dex has reported Non Operating Investment Income for 10 years, with the latest figure at $2.4 million in Q1 2026.
- Quarterly Non Operating Investment Income rose 109.08% year-over-year to $2.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $5.3 million (up 303.73% YoY) and the FY2025 annual result came in at $1.5 million, up 136.87% from the prior year.
- Non Operating Investment Income grew to $2.4 million in Q1 2026 per PDEX's latest filing, from -$250000.0 in the prior quarter.
- Over five years, Non Operating Investment Income peaked at $3.3 million in Q3 2025 and troughed at -$2.6 million in Q3 2023.
- A 5-year average of $424294.1 and a median of $242000.0 in 2023 frame the typical range for Non Operating Investment Income.
- The sharpest annual moves came in 2022 and 2023: Non Operating Investment Income jumped 3361.9% in 2022, then sank 700.71% in 2023.
- Over 5 years, Non Operating Investment Income stood at $2.7 million in 2022, then tumbled by 101.46% to -$40000.0 in 2023, then soared by 292.5% to $77000.0 in 2024, then slumped by 424.68% to -$250000.0 in 2025, then soared by 1057.6% to $2.4 million in 2026.
- According to Business Quant data, Non Operating Investment Income over the past three periods registered $2.4 million, -$250000.0, and $3.3 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Operating Investment Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn | - |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn | - |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn | - |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn | 1.00 Mn |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn | - |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn | - |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn | - |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn | - |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | - |
| 10 | Pro Dex | 209.47 Mn | 198.49 Mn | 6.13 Mn | 2.39 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.39 Mn |
| Mar 31, 2026 | 2.39 Mn |
| Dec 31, 2025 | -250,000.00 |
| Dec 31, 2025 | -250,000.00 |
| Sep 30, 2025 | 3.30 Mn |
| Sep 30, 2025 | 3.30 Mn |
| Jun 30, 2025 | -134,000.00 |
| Jun 30, 2025 | -134,000.00 |
| Mar 31, 2025 | 1.15 Mn |
| Mar 31, 2025 | 1.15 Mn |
| Dec 31, 2024 | 77,000.00 |
| Dec 31, 2024 | 77,000.00 |
| Sep 30, 2024 | 433,000.00 |
| Sep 30, 2024 | 433,000.00 |
| Jun 30, 2024 | -340,000.00 |
| Jun 30, 2024 | -340,000.00 |
| Mar 31, 2024 | -1.19 Mn |
| Mar 31, 2024 | -1.19 Mn |
| Dec 31, 2023 | -40,000.00 |
| Dec 31, 2023 | -40,000.00 |